NEW YORK, July 10 (GenomeWeb News) - Mendel Biotechnology said today that it has extended through 2011 a research and commercialization partnership with Monsanto that began in 1997.
Monsanto and Mendel plan to add a systems biology component to the program, in order to develop "an integrated framework for predictive control of plant gene expression. "
Under the original agreement, Mendel carried out a functional genomics program in Arabidopsis in order to study factors that control plant gene expression. That program identified several genes that have been shown to enhance the yield of major crops in field trials, Mendel said.
These genes are currently in early commercial development by Monsanto and the companies will continue to advance them toward commercialization under the extended agreement.
Mendel will receive milestone and royalty payments from products that Monsanto commercializes.